Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy August 30, 2020 Auto Bot Austin, Bayer, BioPharma, biopharma nl, cancer, CAR-T, cell therapy, Immunotherapy, Northpond Ventures, Oncology, Startups, Texas 0 The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology – currently in preclinical development – into human clinical trials. German drugmaker Bayer’s venture capital arm led the round.